Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
Recent studies add new data to diagnostics research
August 26th, 2005
Investigators in Austria, Japan and France have published new diagnostics data. Study 1: Better non-invasive markers for chronic hepatitis C-related fibrosis are needed. "Liver biopsy is recommended before antiviral treatment, particularly for patients with hepatitis C virus (HCV) genotype 1 infection, but it may cause complications and is limited by sampling error. Several non-invasive tests comprising routine laboratory parameters (simple fibrosis tests) have been proposed to predict fibrosis in chronic HCV," investigators in Austria report. "The aim of the current study was to validate and compare the diagnostic accuracies of...
Source: Drug Week (2005-08-26)
|
